Table 1.
Characteristics of included studiesa
First author, year | Coronavirus b | Study design | Infection | n patients/samples | Index test type | Index test name | Type of specimen | Reference standard |
---|---|---|---|---|---|---|---|---|
Nolte FS, 2007 [40] | OC43, NL63 | Retrospective | ILI | 27 | Multiplex RT-PCR | EraGen Bioscience2 | Nasopharyngeal, nose, throat, and lung tissue, BAL, sputum | Real-time RT-PCR |
Gadsby NJ, 2010 [20] | OC43, 229E, NL63, HKU1 | Retrospective | ILI | 286 | Multiplex real-time RT-PCR | Luminex Molecular Diagnostics | NPS, BAL | Real-time RT-PCR |
Gharabaghi F, 2011 [21] | OC43/HKU1, 229E/NL63 | Retrospective | ILI | 750 | Multiplex RT-PCR | Seegene | NPS | Multiplex RT-PCR |
Pabbaraju K, 2011 [42] | 229E, HKU1, NL63, OC43 | Prospective | NR | 334 | Multiplex RT-PCR | Luminex NxTAG Respiratory | NPS, NPA, nasal swab, throat swab, BAL, sputum, unkown respiratory origin | Multiplex RT-PCR |
Bierbaum S, 2012 [12] | HKU1, NL63, OC43, 229E | Prospective | Upper and lower tract infection symptoms | 300 | Multiplex RT-PCR | Qiagen | Pharyngeal swabs/nasopharyngeal spirates | Monoplex real-time RT-PCR |
Li J, 2012 [31] | OC43, NL63, 229E, HKU1 | Prospective | Pneumonitis, broncho-pneumonia | 126 | Multiplex RT-PCR | GeXP multiplex RT-PCR assay | Nasopharyngeal aspirate | Multiplex RT-PCR |
Puppe W, 2012 [44] | OC43, 229E | Retrospective | NR | 178 | Multiplex RT-PCR | BioRad iCycler, Perkin-Elmer GeneAmp | Nasopharyngeal aspirate, NPS, BAL | Culture, RT-PCR |
Sakthivel SK, 2012 [48] | OC43, 229E, NL63 | Prospective | ILI | 308 | Multiplex real-time RT-PCR | Applied Biosystems | Nasopharyngeal aspirates | Real-time RT-PCR |
Choudhary ML, 2013 [16] | OC43 | Retrospective | ILI/severe acute respiratory illness | 843 | Multiplex RT-PCR | GeneAmp PCR System 9700 | Nasal, nasopharyngeal, throat swab | Real-time RT-PCR |
Kim HK, 2013 [28] | OC43/HKU1 | Mixed | ILI | 482 | Multiplex real-time RT-PCR | Seegene | Nasopharyngeal aspirate, NPS, BAL | Multiplex RT-PCR |
Li J, 2013 [32] | OC43, NL63, 229E, HKU1 | Prospective | ILI, Pneumonia | 247 | Multiplex RT-PCR | Qiagen | Nasopharyngeal aspirate | Multiplex RT-PCR |
Bierbaum S, 2014 [11] | OC43, NL63, 229E | Prospective | ILI | 369 | Multiplex real-time RT-PCR | Inhouse | 214 pharyngeal swab, 152 nasopharyngeal aspirates, 3 BAL | Monoplex real-time RT-PCR |
Salez N, 2015 [49] | Any COV, 229E, NL63, OC43, HKU1 | Prospective | ILI | 166 | Multiplex RT-PCR | RespiFinder SMART 22 | NPS | Duplex PCR or RT-PCR |
Beckmann C, 2016 [10] | OC43, 229E, HKU1, NL63 | Mixed | ILI | 282 | Multiplex RT-PCR | Luminex NxTAG Respiratory | NPS, BAL, throat swabs, tracheal secretion, sputum | Multiplex RT-PCR (MLPA) |
Chen H, 2017 [15] | OC43, 229E, HKU1, NL63 | Prospective | CAP | 74 | Multiplex RT-PCR | BioFire FilmArray Respiratory | Nasal swab | Multiplex real-time RT-PCR |
Ko DH, 2017 [29] | OC43/HKU1, NL63, 229E | Retrospective | NR | 254 | Multiplex RT-PCR | Luminex NxTAG Respiratory | Sputum, NPS | Multiplex real-time RT-PCR |
Mohamed DH, 2017 [37] | MERS-CoV | Retrospective | ILI | 234 | Real-time RT-PCR | NR | NPS/oropharyngeal swab | Real-time RT-PCR |
Babady NE, 2018 [8] | NR | Mixed | ILI | 2908 | Multiplex RT-PCR | GenMark ePlex Respiratory | NPS | Multiplex RT-PCR |
Leber AL, 2018 [30] | HKU1, 229E, NL63, OC43 | Prospective | ILI | 1612 | Multiplex RT-PCR | BioFire FilmArray RP2 | NPS | Multiplex RT-PCR |
Vos LM, 2018 [52] | NR | Prospective | ILI | 62 | Multiplex RT-PCR | BioFire FilmArray Respiratory | NPS | Real-time RT-PCR |
Hecht LS, 2019 [24] | MERS-CoV | Retrospective | ILI | 29 | Real-time RT-PCR | RealStar MERS-CoV | Nasal swab, nasopharyngeal aspirates | Real-time RT-PCR |
Li X, 2019 [33] | NR | Prospective | CAP | 289 | Multiplex RT-PCR | Ningbo HEALTH Gene | Sputum, BAL, pharyngeal swab | Multiplex RT-PCR |
Assennato SM, preprint [7] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19 | 172 | RT-LAMP | SAMBA-II | NPS | Real-time RT-PCR |
Basu A, 2020 [9] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 101 | Isothermal amplification | Abbott ID NOW | Nasal swab | Real-time RT-PCR |
Bisoffi Z, preprint [13] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 345 | Real-time RT-PCR | CDC 2019-Novel Coronavirus | NPS | Real-time RT-PCR, serology + clinical |
Brandsma E, preprint [14] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19 | 378 | RT-LAMP + Cas12 | DETECTR | NPS, BAL, sputum | qRT-PCR |
Collier D, preprint [17] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 149 | RT-LAMP | SAMBA-II | NPS | RT-PCR |
Cradic K, 2020 [18] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 184 | Isothermal amplification | Abbott ID NOW | NPS | Real-time RT-PCR |
Dao Thi VL, preprint [19] | SARS-CoV-2 | Retrospective | NR | 775 | RT-LAMP | Inhouse | Pharyngeal swabs | RT-PCR |
Ghofrani M, preprint [22] | SARS-CoV-2 | Prospective | Symptoms of COVID-19, proven COVID-19 | 113 | Isothermal amplification | Abbott ID NOW | NPS, nasal, other clinical | PCR |
Harrington A, 2020 [23] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 524 | Isothermal amplification | Abbott ID NOW | Nasal swab | Real-time RT-PCR |
Hogan CA, 2020 [25] | SARS-CoV-2 | Retrospective | NR | 100 | RT-PCR + lateral flow | Accula SARS-CoV-2 POCT | NPS | Real-time RT-PCR |
Hou T, 2020 [26] | SARS-CoV-2 | Retrospective | NR | 114 | CRIPSR | CRIPSR-COVID | NPS, BAL | Metagenomic NGS |
Jiang M, 2020 [27] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 260 | RT-LAMP | Inhouse | NPS, sputum, tears | qRT-PCR |
Loeffelholz MJ, 2020 [34] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 481 | Real-time RT-PCR | Cepheid Xpert/GeneXpert | NPS, pharyngeal swab, tracheal aspirate | Real-time RT-PCR |
Matzkies, LM 2020 [35] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19, asymptomatic | 95 | RT-PCR | VIASURE SARSCoV-2 | NPS/oropharyngeal swab | qRT-PCR |
Mitchell SL, 2020 [36] | SARS-CoV-2 | Retrospective | NR | 61 | Isothermal amplification | Abbott ID NOW | NPS | Real-time RT-PCR |
Moore NM, preprint [38] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19 | 198 | Isothermal amplification | Abbott ID NOW | NPS | Real-time RT-PCR + clinical |
Moran A, 2020 [39] | SARS-CoV-2 | Retrospective | NR | 103 | Real-time RT-PCR | Cepheid Xpert/GeneXpert | NPS and nasal swa | qRT-PCR |
Österdahl MF, preprint [41] | SARS-CoV-2 | Prospective | COVID-19 contacts in nursing home | 21 | RT-LAMP with magnetic bead capture | RT-LAMP with magnetic bead capture | NPS | RT-PCR |
Poljak M, 2020 [43] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 501 | qRT-PCR | Cobas 6800, Roche | Nasopharyngeal/oropharyngeal swab | Real-time RT-PCR |
Poljak M, 2020 [43] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19 | 215 | qRT-PCR | Cobas 6800, Roche | Nasopharyngeal/oropharyngeal swab | Real-time RT-PCR |
Ridgday JP, 2020 [45] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 2442 | Real-time RT-PCR | Cepheid Xpert/GeneXpert and Roche cobas SARS-CoV-2 | NPS | Real-time RT-PCR |
Rodriguez-Manzano J, preprint [46] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19 | 181 | RT-qLAMP | Inhouse | NPS, pharyngeal, nasal swabs | Real-time RT-PCR |
Rohaim MA, preprint [47] | SARS-CoV-2 | Retrospective | NR | 199 | RT-LAMP | RT-LAMP with automatic AI based color interpretation | NPS | Real-time RT-PCR |
Smithgall MC, 2020 [50] | SARS-CoV-2 | Retrospective | NR | 113 | Real-time RT-PCR | Cepheid Xpert/GeneXpert | NPS | RT-PCR |
Suo T, preprint [51] | SARS-CoV-2 | Prospective | Symptoms of COVID-19 | 58 | Droplet Digital PCR | Inhouse | Pharyngeal swabs | RT-PCR + clinical |
Wei S, preprint [53] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19, close contact | 20 | RT-LAMP | Inhouse | NPS | qRT-PCR |
Williams E, preprint [54] | SARS-CoV-2 | Retrospective | Symptoms of COVID-19, close contact | 675 | Heminested, multiplex, tandem real-time RT-PCR | Inhouse | NPS 98% | RT-PCR |
Wolters F, 2020 [55] | SARS-CoV-2 | Retrospective | NR | 60 | Real-time RT-PCR | Cepheid Xpert/GeneXpert | NPS | RT-PCR |
Zhen W, 2020 [56] | SARS-CoV-2 | Mixed | Symptoms of COVID-19 | 104 | Real-time RT-PCR | Applied Biosystems ThermoFisher Scientific | NPS | RT-PCR |
NR, not reported; ILI, influenza-like illness; CAP, community-acquired pneumonia; NPS, nasopharyngeal swab; BAL, bronchoalveolar lavage; MLPA, multiplex ligation-dependent probe amplification technology; NGS, next-generation sequencing; RT-LAMP, reverse transcriptase loop-mediated isothermal amplification.
Studies are sorted by year of publication and author.
In bold: the species selected for the main analysis.